FaunaBio
Rui Song is a Senior Research Scientist at FaunaBio, where responsibilities include assay development, drug screening, and target identification and validation since January 2019. Previously, Rui Song served as an Assistant Project Scientist and Postdoctoral Scholar at the University of California, Berkeley from May 2012 to December 2018, focusing on microRNA functions in the development of multiciliated epithelia and related ciliopathies. Prior experience includes a role as a Research Associate at the University of Nevada, Reno in early 2012. Rui Song holds a Ph.D. in Cellular and Molecular Pharmacology and Physiology from the University of Nevada, Reno (2006-2011) and a B.S. in Biology from Wuhan University (2002-2006).
This person is not in any teams
This person is not in any offices
FaunaBio
Fauna Bio is developing new ways to treat human diseases, such as heart disease and neurodegenerative disease, by adopting mechanisms animals have developed for traits such as hibernation and deep-diving. Founded by three scientists who have intimate knowledge of the best science and resources from the field of non-model organisms, Fauna Bioleverages data from hundreds of species in order to help develop pre-clinical and early clinical testing for new therapeutics targeting human diseases.